Literature DB >> 23850061

Gender-based differences in oxidative stress parameters do not underlie the differences in mood disorders susceptibility between sexes.

C Wiener1, G T Rassier1, M P Kaster1, K Jansen1, R T Pinheiro1, F Klamt2, P V Magalhães3, F Kapczinski3, G Ghisleni4, R A da Silva1.   

Abstract

The present study aimed to determine whether any gender-related difference exists concerning oxidative stress parameters in a population of 231 subjects, and if these changes might be related to gender-associated differences in major depressive disorder (MDD) or bipolar disorder (BD) vulnerability. This is a case-control nested in a population-based study. The initial psychopathology screen was performed with the Mini-International Neuropsychiatric Interview and the diagnostic was further confirmed with the Structured Clinical Interview for DSM-IV. Blood samples were obtained after the interview and the oxidative stress parameters such as uric acid, advanced oxidation protein product (PCC) and lipid hydroperoxides (TBARS) were determined. Our results indicated a higher prevalence of MDD and BD in women when compared to men. In addition, significant gender differences were found in the levels of PCC (0.27±0.27 vs. 0.40±0.31nmol CO/mg protein, men vs. women, respectively; P=0.02) and uric acid (4.88±1.39mg/dL vs. 3.53±1.02mg/dL, men vs. women, respectively; P=0.0001), but not in TBARS (0.013±0.01nmol/mg of protein vs. 0.017±0.02nmol/mg of protein, men vs. women respectively; P=0.243). After sample stratification by gender, no association was found between oxidative stress parameters and clinical diagnosis of MDD and BD for women (P=0.516 for PCC; P=0.620 for TBARS P=0.727 for uric acid) and men (P=0.367 for PCC; P=0.372 for TBARS P=0.664 for uric acid). In this study, women seem more susceptible to oxidative stress than male. However, these gender-based differences do not seem to provide a biochemical basis for the epidemiologic differences in mood disorders susceptibility between sexes.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Gender; Major depressive disorder; Oxidative stress

Mesh:

Substances:

Year:  2013        PMID: 23850061     DOI: 10.1016/j.eurpsy.2013.05.006

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  16 in total

Review 1.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

Review 2.  Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression.

Authors:  Francesco Bartoli; Giulia Trotta; Cristina Crocamo; Maria Rosaria Malerba; Massimo Clerici; Giuseppe Carrà
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-15       Impact factor: 5.270

3.  Serum uric acid is not associated with major depressive disorder in European and South American populations: a meta-analysis and two-sample bidirectional Mendelian Randomization study.

Authors:  Zefeng Chen; Shuang Liang; Yulan Bai; Jiali Lin; Mingli Li; Zengnan Mo; Sisi Xie; ShiShan Huang; Jianxiong Long
Journal:  Eur J Clin Nutr       Date:  2022-05-25       Impact factor: 4.016

4.  Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats.

Authors:  Helena M Abelaira; Thayse Rosa; Airam B de Moura; Natalia M Andrade; Nicoly S Martinello; Larissa R Maciel; Maria Eduarda M Botelho; Laura A Borba; Beatriz C Chede; Camila O Arent; Larissa Joaquim; Sandra Bonfante; Lucinéia G Danielski; Talita Tuon; Fabricia Petronilho; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2022-01-07       Impact factor: 5.590

5.  Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder.

Authors:  Yuncheng Zhu; Haifeng Ji; Zhiang Niu; Hongmei Liu; Xiaohui Wu; Lu Yang; Zuowei Wang; Jun Chen; Yiru Fang
Journal:  Front Psychiatry       Date:  2022-06-20       Impact factor: 5.435

6.  The Relationship between F2-Isoprostanes Plasma Levels and Depression Symptoms in Healthy Older Adults.

Authors:  Karen Savage; Lee Gogarty; Ana Lea; Saurenne Deleuil; Karen Nolidin; Kevin Croft; Con Stough
Journal:  Antioxidants (Basel)       Date:  2022-04-22

7.  Elevated plasma F2-isoprostane levels in schizophrenia.

Authors:  Ellen E Lee; Lisa T Eyler; Owen M Wolkowitz; Averria Sirkin Martin; Chase Reuter; Helena Kraemer; Dilip V Jeste
Journal:  Schizophr Res       Date:  2016-06-16       Impact factor: 4.939

8.  Comparison of Serum Uric Acid in Major Depressive Disorder and Bipolar Disorder: a Retrospective Chart Review Study.

Authors:  Soomin Kim; Sang Jin Rhee; Yoojin Song; Yong Min Ahn
Journal:  J Korean Med Sci       Date:  2020-07-20       Impact factor: 2.153

9.  Obesity moderates the complex relationships between inflammation, oxidative stress, sleep quality and depressive symptoms.

Authors:  Alanna V Rigobon; Thirumagal Kanagasabai; Valerie H Taylor
Journal:  BMC Obes       Date:  2018-12-03

10.  A Meta-Analysis of Oxidative Stress Markers in Depression.

Authors:  Tao Liu; Shuming Zhong; Xiaoxiao Liao; Jian Chen; Tingting He; Shunkai Lai; Yanbin Jia
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.